Oxford University Clinical Research Unit, Hanoi, Viet Nam.
BMC Public Health. 2013 Dec 10;13:1158. doi: 10.1186/1471-2458-13-1158.
Antimicrobial resistance is a major contemporary public health threat. Strategies to contain antimicrobial resistance have been comprehensively set forth, however in developing countries where the need for effective antimicrobials is greatest implementation has proved problematic. A better understanding of patterns and determinants of antibiotic use and resistance in emerging economies may permit more appropriately targeted interventions.Viet Nam, with a large population, high burden of infectious disease and relatively unrestricted access to medication, is an excellent case study of the difficulties faced by emerging economies in controlling antimicrobial resistance.
Our working group conducted a situation analysis of the current patterns and determinants of antibiotic use and resistance in Viet Nam. International publications and local reports published between 1-1-1990 and 31-8-2012 were reviewed. All stakeholders analyzed the findings at a policy workshop and feasible recommendations were suggested to improve antibiotic use in Viet Nam.Here we report the results of our situation analysis focusing on: the healthcare system, drug regulation and supply; antibiotic resistance and infection control; and agricultural antibiotic use.
Market reforms have improved healthcare access in Viet Nam and contributed to better health outcomes. However, increased accessibility has been accompanied by injudicious antibiotic use in hospitals and the community, with predictable escalation in bacterial resistance. Prescribing practices are poor and self-medication is common - often being the most affordable way to access healthcare. Many policies exist to regulate antibiotic use but enforcement is insufficient or lacking.Pneumococcal penicillin-resistance rates are the highest in Asia and carbapenem-resistant bacteria (notably NDM-1) have recently emerged. Hospital acquired infections, predominantly with multi-drug resistant Gram-negative organisms, place additional strain on limited resources. Widespread agricultural antibiotic use further propagates antimicrobial resistance.
Future legislation regarding antibiotic access must alter incentives for purchasers and providers and ensure effective enforcement. The Ministry of Health recently initiated a national action plan and approved a multicenter health improvement project to strengthen national capacity for antimicrobial stewardship in Viet Nam. This analysis provided important input to these initiatives. Our methodologies and findings may be of use to others across the world tackling the growing threat of antibiotic resistance.
抗生素耐药性是当前主要的公共卫生威胁。已经全面制定了控制抗生素耐药性的策略,然而在发展中国家,对有效抗生素的需求最大,实施证明存在问题。更好地了解新兴经济体中抗生素使用和耐药性的模式和决定因素,可能会使干预措施更有针对性。越南人口众多,传染病负担沉重,药物获取相对不受限制,是新兴经济体在控制抗生素耐药性方面面临困难的一个极好案例。
我们的工作组对越南目前抗生素使用和耐药模式及其决定因素进行了情况分析。审查了 1990 年 1 月 1 日至 2012 年 8 月 31 日期间发表的国际出版物和当地报告。所有利益攸关方在政策研讨会上分析了研究结果,并提出了改善越南抗生素使用的可行建议。在这里,我们报告了我们的情况分析结果,重点关注:医疗保健系统、药品监管和供应;抗生素耐药性和感染控制;以及农业抗生素使用。
市场改革改善了越南的医疗保健可及性,并促进了更好的健康结果。然而,增加可及性伴随着医院和社区不合理的抗生素使用,细菌耐药性随之可预测地升级。处方实践不佳,自我用药很常见——通常是获得医疗保健的最经济方式。存在许多政策来规范抗生素的使用,但执行不力或缺乏执行。肺炎球菌对青霉素的耐药率在亚洲最高,最近出现了耐碳青霉烯类抗生素的细菌(尤其是 NDM-1)。医院获得性感染,主要是耐多药革兰氏阴性菌,给有限的资源带来了额外的压力。广泛的农业抗生素使用进一步加剧了抗生素耐药性。
未来关于抗生素获取的立法必须改变购买者和提供者的激励措施,并确保有效执行。卫生部最近启动了国家行动计划,并批准了一个多中心卫生改善项目,以加强越南国家的抗生素管理能力。这项分析为这些举措提供了重要的投入。我们的方法和研究结果可能对全球其他国家应对抗生素耐药性日益增长的威胁有用。